Abiopharma

🔍 Meiklejohn Mark J. (Executive)

Company: Beacon Financial Corp (BBT)

Report Date: 2026-06-16

Detailed Transactions and Holdings:

• Acquired 4,420 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 53,182.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,420 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 57,602.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Restricted stock shares granted pursuant to the 2025 Beacon Financial Corporation Stock Option and Incentive Plan. The shares vest in three equal installments on an annual basis, commencing one year from the date of grant.
• F2: Performance based restricted stock shares granted pursuant to the 2025 Beacon Financial Corporation Stock Option and Incentive Plan. The shares vest on the third anniversary of the date of grant based on certain performance based metrics.
• F3: Includes shares of restricted stock granted pursuant to the 2025 Beacon Financial Corporation Stock Option and Incentive Plan.